{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:30:48Z","timestamp":1789000248250,"version":"build-2803163510"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673403"],"award-info":[{"award-number":["81673403"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.bcp.2021.114727","type":"journal-article","created":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T13:42:38Z","timestamp":1628689358000},"page":"114727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Thalidomide alleviates neuropathic pain through microglial IL-10\/\u03b2-endorphin signaling pathway"],"prefix":"10.1016","volume":"192","author":[{"given":"Meng-Yan","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalil Ali","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao-Qiao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana Muhammad","family":"Shoaib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Xiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bcp.2021.114727_b0005","doi-asserted-by":"crossref","DOI":"10.3390\/ph13050095","article-title":"Molecular mechanisms of the teratogenic effects of thalidomide","volume":"13","author":"Asatsuma-Okumura","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"issue":"3","key":"10.1016\/j.bcp.2021.114727_b0010","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1358\/dot.2004.40.3.820083","article-title":"The promise of thalidomide: evolving indications","volume":"40","author":"Joglekar","year":"2004","journal-title":"Drugs Today (Barc)"},{"issue":"5","key":"10.1016\/j.bcp.2021.114727_b0015","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s40265-017-0689-1","article-title":"Immunomodulatory drugs in multiple myeloma: mechanisms of action and clinical experience","volume":"77","author":"Holstein","year":"2017","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.bcp.2021.114727_b0020","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nrc1323","article-title":"The evolution of thalidomide and its IMiD derivatives as anticancer agents","volume":"4","author":"Bartlett","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.bcp.2021.114727_b0025","first-page":"846","article-title":"Immunomodulatory drugs (IMiDs) in multiple myeloma","volume":"17","author":"Raza","year":"2017","journal-title":"Curr. Cancer Drug Targets"},{"issue":"8","key":"10.1016\/j.bcp.2021.114727_b0030","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1586\/14737140.6.8.1165","article-title":"Lenalidomide in multiple myeloma","volume":"6","author":"Richardson","year":"2006","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"5","key":"10.1016\/j.bcp.2021.114727_b0035","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1586\/14737140.2014.906904","article-title":"Pomalidomide for the treatment of relapsed\u2013refractory multiple myeloma: a review of biological and clinical data","volume":"14","author":"Offidani","year":"2014","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"2","key":"10.1016\/j.bcp.2021.114727_b0040","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S1016-8478(23)13028-7","article-title":"The effects of thalidomide on the stimulation of NF-kappaB activity and TNF-alpha production by lipopolysaccharide in a human colonic epithelial cell line","volume":"17","author":"Kim","year":"2004","journal-title":"Mol. Cells"},{"issue":"6","key":"10.1016\/j.bcp.2021.114727_b0045","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1084\/jem.177.6.1675","article-title":"Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation","volume":"177","author":"Moreira","year":"1993","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.bcp.2021.114727_b0050","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1046\/j.1523-1747.2003.12565.x","article-title":"Thalidomide inhibits tumor necrosis factor-alpha production and antigen presentation by Langerhans cells","volume":"121","author":"Deng","year":"2003","journal-title":"J, Invest. Dermatol."},{"issue":"11","key":"10.1016\/j.bcp.2021.114727_b0055","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/S0960-894X(99)00250-4","article-title":"Amino-substituted thalidomide analogs: Potent inhibitors of TNF-\u03b1 production","volume":"9","author":"Muller","year":"1999","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"9","key":"10.1016\/j.bcp.2021.114727_b0060","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1182\/blood-2002-03-0996","article-title":"Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma","volume":"100","author":"Richardson","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bcp.2021.114727_b0065","doi-asserted-by":"crossref","first-page":"380","DOI":"10.4049\/jimmunol.163.1.380","article-title":"Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha","volume":"163","author":"Corral","year":"1999","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114727_b0070","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1182\/blood.V98.1.210","article-title":"Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma","volume":"98","author":"Davies","year":"2001","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.bcp.2021.114727_b0075","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1124\/jpet.102.048496","article-title":"Enhancement of cytokine production and AP-1 transcriptional activity in T cells by thalidomide-related immunomodulatory drugs","volume":"305","author":"Schafer","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2021.114727_b0080","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/leu.2009.236","article-title":"Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma","volume":"24","author":"Quach","year":"2010","journal-title":"Leukemia"},{"issue":"20","key":"10.1016\/j.bcp.2021.114727_b0085","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1001\/archinte.161.20.2502","article-title":"Complete resolution of reflex sympathetic dystrophy with thalidomide treatment","volume":"161","author":"Rajkumar","year":"2001","journal-title":"Arch. Intern. Med."},{"issue":"12","key":"10.1016\/j.bcp.2021.114727_b0090","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1001\/archinte.163.12.1487","article-title":"Thalidomide has activity in treating complex regional pain syndrome","volume":"163","author":"Schwartzman","year":"2003","journal-title":"Arch. Intern. Med."},{"issue":"2","key":"10.1016\/j.bcp.2021.114727_b0095","first-page":"96","article-title":"Successful treatment with low-dose thalidomide in a patient with both beh\u00e7et's disease and complex regional pain syndrome type i: case report","volume":"9","author":"Ching","year":"2003","journal-title":"JCR: J. Clin. Rheumatol."},{"issue":"2","key":"10.1016\/j.bcp.2021.114727_b0100","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11926-002-0012-2","article-title":"Reflex sympathetic dystrophy","volume":"4","author":"Schwartzman","year":"2002","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.bcp.2021.114727_b0105","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.2147\/JPR.S213112","article-title":"Systemic injection of thalidomide prevent and attenuate neuropathic pain and alleviate neuroinflammatory response in the spinal dorsal horn","volume":"12","author":"Xu","year":"2019","journal-title":"J Pain Res"},{"issue":"4","key":"10.1016\/j.bcp.2021.114727_b0110","doi-asserted-by":"crossref","first-page":"331","DOI":"10.4097\/kjae.2013.65.4.331","article-title":"Synergistic anti-allodynic effect between intraperitoneal thalidomide and morphine on rat spinal nerve ligation-induced neuropathic pain","volume":"65","author":"Lee","year":"2013","journal-title":"Korean J. Anesthesiol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114727_b0115","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0304-3959(97)00154-1","article-title":"The effect of thalidomide treatment on vascular pathology and hyperalgesia caused by chronic constriction injury of rat nerve","volume":"74","author":"Sommer","year":"1998","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.bcp.2021.114727_b0120","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10787-011-0106-4","article-title":"Possible mechanism of protective effect of thalidomide in STZ-induced-neuropathic pain behavior in rats","volume":"20","author":"Taliyan","year":"2012","journal-title":"Inflammopharmacology"},{"issue":"3","key":"10.1016\/j.bcp.2021.114727_b0125","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0304-3959(00)00333-X","article-title":"Thalidomide treatment in chronic constrictive neuropathy decreases endoneurial tumor necrosis factor-alpha, increases interleukin-10 and has long-term effects on spinal cord dorsal horn met-enkephalin","volume":"88","author":"George","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.bcp.2021.114727_b0130","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.brainres.2012.02.033","article-title":"The thalidomide analgesic effect is associated with differential TNF-\u03b1 receptor expression in the dorsal horn of the spinal cord as studied in a rat model of neuropathic pain","volume":"1450","author":"Andrade","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.bcp.2021.114727_b0135","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.brainres.2008.07.001","article-title":"The effects of thalidomide and minocycline on taxol-induced hyperalgesia in rats","volume":"1229","author":"Cata","year":"2008","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.bcp.2021.114727_b0140","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1517\/14740338.2013.775242","article-title":"Lenalidomide and thalidomide in the treatment of chronic pain","volume":"12","author":"Asher","year":"2013","journal-title":"Expert. Opin. Drug Saf."},{"issue":"12","key":"10.1016\/j.bcp.2021.114727_b0145","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.jpain.2014.09.013","article-title":"Lenalidomide for complex regional pain syndrome type 1: lack of efficacy in a phase II randomized study","volume":"15","author":"Manning","year":"2014","journal-title":"J. Pain"},{"issue":"1","key":"10.1016\/j.bcp.2021.114727_b0150","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/jdi.12379","article-title":"Microglia in the spinal cord and neuropathic pain","volume":"7","author":"Tsuda","year":"2016","journal-title":"J. Diabetes Invest."},{"issue":"2","key":"10.1016\/j.bcp.2021.114727_b0155","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.tins.2004.12.002","article-title":"Neuropathic pain and spinal microglia: a big problem from molecules in \u2018small\u2019 glia","volume":"28","author":"Tsuda","year":"2005","journal-title":"Trends Neurosci."},{"issue":"3","key":"10.1016\/j.bcp.2021.114727_b0160","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/nrn.2018.2","article-title":"Microglia in neuropathic pain: cellular and molecular mechanisms and therapeutic potential","volume":"19","author":"Inoue","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bcp.2021.114727_b0165","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/753656","article-title":"Microglia and spinal cord synaptic plasticity in persistent pain","volume":"2013","author":"Taves","year":"2013","journal-title":"Neural Plasticity"},{"issue":"3","key":"10.1016\/j.bcp.2021.114727_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.pain.2006.03.011","article-title":"The role of tumor necrosis factor-alpha in the neuropathic pain induced by Lumbar 5 ventral root transection in rat","volume":"123","author":"Xu","year":"2006","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.bcp.2021.114727_b0175","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/00001756-200002280-00033","article-title":"Transgenic expression of TNF by astrocytes increases mechanical allodynia in a mouse neuropathy model","volume":"11","author":"DeLeo","year":"2000","journal-title":"NeuroReport"},{"issue":"3","key":"10.1016\/j.bcp.2021.114727_b0180","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1053\/eujp.2000.0177","article-title":"Intrathecally administered endotoxin or cytokines produce allodynia, hyperalgesia and changes in spinal cord neuronal responses to nociceptive stimuli in the rat","volume":"4","author":"Reeve","year":"2000","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.bcp.2021.114727_b0185","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1002\/jnr.21726","article-title":"Exogenous tumor necrosis factor-alpha rapidly alters synaptic and sensory transmission in the adult rat spinal cord dorsal horn","volume":"86","author":"Youn","year":"2008","journal-title":"J. Neurosci. Res."},{"issue":"11","key":"10.1016\/j.bcp.2021.114727_b0190","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S1286-4579(02)01645-3","article-title":"Thalidomide in the treatment of leprosy","volume":"4","author":"Teo","year":"2002","journal-title":"Microbes Infect."},{"issue":"1486","key":"10.1016\/j.bcp.2021.114727_b0195","article-title":"Thalidomide prevented and ameliorated pathogenesis of crohn\u2019s disease in mice via regulation of inflammatory response and fibrosis","volume":"10","author":"Chen","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114727_b0200","first-page":"64","article-title":"Intraperitoneal injection of thalidomide attenuates bone cancer pain and decreases spinal tumor necrosis factor-\u03b1 expression in a mouse model","volume":"6","author":"Gu","year":"2010","journal-title":"Molecular pain"},{"issue":"10","key":"10.1016\/j.bcp.2021.114727_b0205","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1590\/S0100-879X1997001000010","article-title":"Thalidomide protects mice against LPS-induced shock","volume":"30","author":"Moreira","year":"1997","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"3","key":"10.1016\/j.bcp.2021.114727_b0210","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.exer.2006.11.009","article-title":"Preventive and therapeutic anti-inflammatory effects of systemic and topical thalidomide on endotoxin-induced uveitis in rats","volume":"84","author":"Rodrigues","year":"2007","journal-title":"Exp. Eye Res."},{"issue":"1","key":"10.1016\/j.bcp.2021.114727_b0215","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0304-3959(97)00148-6","article-title":"Anti-inflammatory interleukin-10 therapy in CCI neuropathy decreases thermal hyperalgesia, macrophage recruitment, and endoneurial TNF-alpha expression","volume":"74","author":"Wagner","year":"1998","journal-title":"Pain"},{"issue":"43","key":"10.1016\/j.bcp.2021.114727_b0220","doi-asserted-by":"crossref","first-page":"11074","DOI":"10.1523\/JNEUROSCI.3708-15.2016","article-title":"CD8+ T Cells and Endogenous IL-10 Are Required for Resolution of Chemotherapy-Induced Neuropathic Pain","volume":"36","author":"Krukowski","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2021.114727_b0225","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.bbi.2018.06.015","article-title":"Spinal interleukin-10 produces antinociception in neuropathy through microglial \u03b2-endorphin expression, separated from antineuroinflammation","volume":"73","author":"Wu","year":"2018","journal-title":"Brain Behav. Immun."},{"issue":"48","key":"10.1016\/j.bcp.2021.114727_b0230","doi-asserted-by":"crossref","first-page":"11701","DOI":"10.1523\/JNEUROSCI.1799-17.2017","article-title":"Autocrine interleukin-10 mediates glucagon-like peptide-1 receptor-induced spinal microglial \u03b2-endorphin expression","volume":"37","author":"Wu","year":"2017","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.bcp.2021.114727_b0235","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12974-019-1616-z","article-title":"The spinal microglial IL-10\/\u03b2-endorphin pathway accounts for cinobufagin-induced mechanical antiallodynia in bone cancer pain following activation of \u03b17-nicotinic acetylcholine receptors","volume":"17","author":"Apryani","year":"2020","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.bcp.2021.114727_b0240","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12974-019-1457-9","article-title":"Activation of GPR40 produces mechanical antiallodynia via the spinal glial interleukin-10\/\u03b2-endorphin pathway","volume":"16","author":"Mao","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bcp.2021.114727_b0245","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.614450","article-title":"Cynandione A Alleviates Neuropathic Pain Through \u03b17-nAChR-Dependent IL-10\/\u03b2-Endorphin Signaling Complexes","volume":"11","author":"Han","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114727_b0250","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12974-016-0696-2","article-title":"Bullatine A stimulates spinal microglial dynorphin A expression to produce anti-hypersensitivity in a variety of rat pain models","volume":"13","author":"Huang","year":"2016","journal-title":"J. Neuroinflammation"},{"issue":"17","key":"10.1016\/j.bcp.2021.114727_b0255","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1021\/jm9603328","article-title":"Structural modifications of thalidomide produce analogs with enhanced tumor necrosis factor inhibitory activity","volume":"39","author":"Muller","year":"1996","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2021.114727_b0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055091","article-title":"Long-term treatment of thalidomide ameliorates amyloid-like pathology through inhibition of \u03b2-secretase in a mouse model of Alzheimer's disease","volume":"8","author":"He","year":"2013","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.bcp.2021.114727_b0265","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/infdis\/172.4.1137","article-title":"Thalidomide inhibits tumor necrosis factor-alpha production by lipopolysaccharide- and lipoarabinomannan-stimulated human microglial cells","volume":"172","author":"Peterson","year":"1995","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bcp.2021.114727_b0270","doi-asserted-by":"crossref","unstructured":"T. Korhonen, J. Karppinen, A. Malmivaara, R. Autio, J. Niinim\u00e4ki, L. Paimela, E. Kyll\u00f6nen, K.A. Lindgren, O. Tervonen, S. Seitsalo, H. Hurri, Efficacy of infliximab for disc herniation-induced sciatica: one-year follow-up, Spine (Phila Pa 1976) 29(19) (2004) 2115-9.","DOI":"10.1097\/01.brs.0000141179.58778.6c"},{"key":"10.1016\/j.bcp.2021.114727_b0275","doi-asserted-by":"crossref","unstructured":"T. Korhonen, J. Karppinen, L. Paimela, A. Malmivaara, K.A. Lindgren, S. J\u00e4rvinen, J. Niinim\u00e4ki, N. Veeger, S. Seitsalo, H. Hurri, The treatment of disc herniation-induced sciatica with infliximab: results of a randomized, controlled, 3-month follow-up study, Spine (Phila Pa 1976) 30(24) (2005) 2724-8.","DOI":"10.1097\/01.brs.0000190815.13764.64"},{"key":"10.1016\/j.bcp.2021.114727_b0280","doi-asserted-by":"crossref","unstructured":"T. Korhonen, J. Karppinen, L. Paimela, A. Malmivaara, K.A. Lindgren, C. Bowman, A. Hammond, B. Kirkham, S. J\u00e4rvinen, J. Niinim\u00e4ki, N. Veeger, M. Haapea, M. Torkki, O. Tervonen, S. Seitsalo, H. Hurri, The treatment of disc-herniation-induced sciatica with infliximab: one-year follow-up results of FIRST II, a randomized controlled trial, Spine (Phila Pa 1976) 31(24) (2006) 2759-66.","DOI":"10.1097\/01.brs.0000245873.23876.1e"},{"issue":"18","key":"10.1016\/j.bcp.2021.114727_b0285","article-title":"Temporal expression of cytokines and their receptors mRNAs in a neuropathic pain model","volume":"15","author":"Lee","year":"2004","journal-title":"NeuroReport"},{"issue":"1","key":"10.1016\/j.bcp.2021.114727_b0290","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1006\/exnr.2002.7897","article-title":"Effect of lumbar 5 ventral root transection on pain behaviors: a novel rat model for neuropathic pain without axotomy of primary sensory neurons","volume":"175","author":"Li","year":"2002","journal-title":"Exp. Neurol."},{"issue":"8","key":"10.1016\/j.bcp.2021.114727_b0295","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jpain.2013.02.011","article-title":"Descending facilitation maintains long-term spontaneous neuropathic pain","volume":"14","author":"Wang","year":"2013","journal-title":"J. Pain"},{"issue":"7","key":"10.1016\/j.bcp.2021.114727_b0300","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1523\/JNEUROSCI.23-07-02517.2003","article-title":"Tumor necrosis factor-\u03b1 induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons","volume":"23","author":"Sch\u00e4fers","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2021.114727_b0305","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.ejpain.2008.08.001","article-title":"Effects of Etanercept and Minocycline in a rat model of spinal cord injury","volume":"13","author":"Marchand","year":"2008","journal-title":"Eur. J. Pain (London, England)"},{"issue":"3","key":"10.1016\/j.bcp.2021.114727_b0310","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/ijo.2015.201","article-title":"IL-10 gene transfer upregulates arcuate POMC and ameliorates hyperphagia, obesity and diabetes by substituting for leptin","volume":"40","author":"Nakata","year":"2016","journal-title":"Int. J. Obesity"},{"issue":"10","key":"10.1016\/j.bcp.2021.114727_b0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047569","article-title":"Endogenous opioids in wound-site neutrophils of sternotomy patients","volume":"7","author":"Awad","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.bcp.2021.114727_b0320","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/BF03401909","article-title":"Selection of novel analogs of thalidomide with enhanced tumor necrosis factor alpha inhibitory activity","volume":"2","author":"Corral","year":"1996","journal-title":"Mol. Med."},{"issue":"5","key":"10.1016\/j.bcp.2021.114727_b0325","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.bbi.2006.10.012","article-title":"Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats","volume":"21","author":"Ledeboer","year":"2007","journal-title":"Brain Behav. Immun."},{"issue":"28","key":"10.1016\/j.bcp.2021.114727_b0330","doi-asserted-by":"crossref","first-page":"7353","DOI":"10.1523\/JNEUROSCI.0092-16.2016","article-title":"IL4-10 Fusion Protein Is a Novel Drug to Treat Persistent Inflammatory Pain","volume":"36","author":"Eijkelkamp","year":"2016","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.bcp.2021.114727_b0335","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1111\/j.1460-9568.2005.04057.x","article-title":"Controlling pathological pain by adenovirally driven spinal production of the anti-inflammatory cytokine, interleukin-10","volume":"21","author":"Milligan","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bcp.2021.114727_b0340","series-title":"Handbook of Biologically Active Peptides (Second Edition)","first-page":"1592","article-title":"Chapter 217 - POMC-Derived Opioid Peptides","author":"McLaughlin","year":"2013"},{"issue":"1","key":"10.1016\/j.bcp.2021.114727_b0345","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/bph.12895","article-title":"The non-peptide GLP-1 receptor agonist WB4-24 blocks inflammatory nociception by stimulating \u03b2-endorphin release from spinal microglia","volume":"172","author":"Fan","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2021.114727_b0350","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.bbi.2017.02.005","article-title":"Cynandione A attenuates neuropathic pain through p38\u03b2 MAPK-mediated spinal microglial expression of \u03b2-endorphin","volume":"62","author":"Huang","year":"2017","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.bcp.2021.114727_b0355","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.bbrc.2020.05.080","article-title":"The GLP-1 receptor herbal agonist morroniside attenuates neuropathic pain via spinal microglial expression of IL-10 and \u03b2-endorphin","volume":"530","author":"Tang","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2021.114727_b0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2020.03.023","article-title":"Lemairamin, isolated from the Zanthoxylum plants, alleviates pain hypersensitivity via spinal \u03b17 nicotinic acetylcholine receptors","volume":"525","author":"Wang","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221003439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221003439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:31:39Z","timestamp":1757770299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295221003439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":72,"alternative-id":["S0006295221003439"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114727","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thalidomide alleviates neuropathic pain through microglial IL-10\/\u03b2-endorphin signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114727","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114727"}}